GlassScriptPhysician profile
Janet Garza
NPI 1356783468
$3,529.98
in general payments reported to CMS, 2019-2025
17 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $170 · 2021: $162 · 2022: $344 · 2023: $523 · 2024: $626 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458 · Consulting Fee: $450 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $225 · Entertainment: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.62 |
| Consulting Fee | $450.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $225.00 |
| Entertainment | $214.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $749.32 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $623.60 | 2019-2025 | Air Optix, Precision 1, Precision 7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $386.94 | 2019-2021 | |
| Optos, INC. | $369.64 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $233.84 | 2024-2025 | Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $233.84 | 2024-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $192.61 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $180.70 | 2020-2022 | |
| Ocular Therapeutix, INC. | $125.00 | 2024 | Dextenza |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
| Lkc Technologies, INC. | $119.21 | 2023 | |
| Shire North American Group INC | $100.18 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $22.30 | 2019 | |
| Mirum Pharmaceuticals, INC. | $22.22 | 2025 | Ctexli, Cholbam |
| Sun Pharmaceutical Industries INC. | $17.93 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Apellis Pharmaceuticals, INC. | $13.55 | 2024 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.